Veteran biotech investor David Mott departs from NEA
March 06, 2020 at 12:29 PM EST
The biotech exec had overseen $1 billion in health care venture capital at the Chevy Chase firm.
Breaking News Bar
Business News and Information
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
| ||||||
bottom clear
